{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,28]],"date-time":"2026-08-28T01:15:09Z","timestamp":1787879709641,"version":"build-2784847793"},"reference-count":197,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2018,7,1]],"date-time":"2018-07-01T00:00:00Z","timestamp":1530403200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2018,7,1]],"date-time":"2018-07-01T00:00:00Z","timestamp":1530403200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100004381","name":"Western University","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004381","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100014349","name":"Society For Maternal-Fetal Medicine","doi-asserted-by":"publisher","award":["MFM-146443"],"award-info":[{"award-number":["MFM-146443"]}],"id":[{"id":"10.13039\/100014349","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Pregnancy Hypertension"],"published-print":{"date-parts":[[2018,7]]},"DOI":"10.1016\/j.preghy.2018.06.005","type":"journal-article","created":{"date-parts":[[2018,6,9]],"date-time":"2018-06-09T10:50:59Z","timestamp":1528541459000},"page":"204-213","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":22,"special_numbering":"C","title":["Preeclampsia biomarkers: An assessment of maternal cardiometabolic health"],"prefix":"10.1016","volume":"13","author":[{"given":"Genevieve","family":"Eastabrook","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tuba","family":"Aksoy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Samantha","family":"Bedell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Debbie","family":"Penava","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Barbra","family":"de Vrijer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.preghy.2018.06.005_b0005","unstructured":"W. Lerberghe, A. Manuel, Z. Matthews, C. Wolfheim, The World Health Report 2005: Make Every Mother and Child Count, 2005."},{"key":"10.1016\/j.preghy.2018.06.005_b0010","unstructured":"P.H.A.O. Canada, Canadian Perinatal Health Report, 2008 Edition, Ottawa, 2008."},{"issue":"5","key":"10.1016\/j.preghy.2018.06.005_b0015","doi-asserted-by":"crossref","first-page":"416","DOI":"10.1016\/S1701-2163(15)30588-0","article-title":"Hypertensive disorders of pregnancy working, diagnosis, evaluation, and management of the hypertensive disorders of pregnancy: executive summary","volume":"36","author":"Magee","year":"2014","journal-title":"J. Obstet. Gynaecol. Can."},{"key":"10.1016\/j.preghy.2018.06.005_b0020","doi-asserted-by":"crossref","first-page":"79","DOI":"10.2147\/IBPC.S77344","article-title":"Current best practice in the management of hypertensive disorders in pregnancy","volume":"9","author":"Townsend","year":"2016","journal-title":"Integr. Blood Press Control."},{"issue":"8","key":"10.1016\/j.preghy.2018.06.005_b0025","doi-asserted-by":"crossref","first-page":"800","DOI":"10.1056\/NEJMoa0706790","article-title":"Preeclampsia and the risk of end-stage renal disease","volume":"359","author":"Vikse","year":"2008","journal-title":"N. Engl. J. Med."},{"issue":"4","key":"10.1016\/j.preghy.2018.06.005_b0030","doi-asserted-by":"crossref","first-page":"1055","DOI":"10.1161\/01.STR.0000206284.96739.ee","article-title":"Preeclampsia and the risk of ischemic stroke among young women: results from the Stroke Prevention in Young Women Study","volume":"37","author":"Brown","year":"2006","journal-title":"Stroke"},{"issue":"4","key":"10.1016\/j.preghy.2018.06.005_b0035","doi-asserted-by":"crossref","first-page":"400","DOI":"10.1016\/j.nwh.2016.07.003","article-title":"Assessment, management, and health implications of early-onset preeclampsia","volume":"20","author":"Phillips","year":"2016","journal-title":"Nurs. Womens Health"},{"issue":"4","key":"10.1016\/j.preghy.2018.06.005_b0040","doi-asserted-by":"crossref","first-page":"3142","DOI":"10.3390\/biom5043142","article-title":"Immune mechanisms linking obesity and preeclampsia","volume":"5","author":"Spradley","year":"2015","journal-title":"Biomolecules"},{"issue":"8","key":"10.1016\/j.preghy.2018.06.005_b0045","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1097\/OGX.0b013e3182331028","article-title":"A critical review of early-onset and late-onset preeclampsia","volume":"66","author":"Raymond","year":"2011","journal-title":"Obstet. Gynecol. Surv."},{"issue":"2","key":"10.1016\/j.preghy.2018.06.005_b0050","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1016\/j.ogc.2009.04.001","article-title":"Childbearing and obesity in women: weight before, during, and after pregnancy","volume":"36","author":"Gunderson","year":"2009","journal-title":"Obstet. Gynecol. Clin. North Am."},{"issue":"6","key":"10.1016\/j.preghy.2018.06.005_b0055","doi-asserted-by":"crossref","first-page":"532","DOI":"10.1111\/ajo.12126","article-title":"Clinical evaluation of a first trimester algorithm predicting the risk of hypertensive disease of pregnancy","volume":"53","author":"Park","year":"2013","journal-title":"Aust. N. Z. J. Obstet. Gynaecol."},{"issue":"5","key":"10.1016\/j.preghy.2018.06.005_b0060","first-page":"334","article-title":"An overview of recent advances in pathogenesis and diagnosis of preeclampsia","volume":"6","author":"Savaj","year":"2012","journal-title":"Iran. J. Kidney Dis."},{"issue":"6","key":"10.1016\/j.preghy.2018.06.005_b0065","doi-asserted-by":"crossref","first-page":"1367","DOI":"10.1097\/01.AOG.0000147599.47713.5d","article-title":"World Health Organization systematic review of screening tests for preeclampsia","volume":"104","author":"Conde-Agudelo","year":"2004","journal-title":"Obstet. Gynecol."},{"issue":"2","key":"10.1016\/j.preghy.2018.06.005_b0070","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1097\/01.ede.0000254119.99660.e7","article-title":"Prepregnancy body mass index and the occurrence of severe hypertensive disorders of pregnancy","volume":"18","author":"Bodnar","year":"2007","journal-title":"Epidemiology"},{"issue":"3","key":"10.1016\/j.preghy.2018.06.005_b0075","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1111\/1471-0528.13050","article-title":"Screening for pre-eclampsia early in pregnancy: performance of a multivariable model combining clinical characteristics and biochemical markers","volume":"122","author":"Giguere","year":"2015","journal-title":"BJOG"},{"issue":"Suppl. 1","key":"10.1016\/j.preghy.2018.06.005_b0080","doi-asserted-by":"crossref","first-page":"S18","DOI":"10.1111\/nure.12055","article-title":"Epidemiology of preeclampsia: impact of obesity","volume":"71","author":"Jeyabalan","year":"2013","journal-title":"Nutr. Rev."},{"issue":"1","key":"10.1016\/j.preghy.2018.06.005_b0085","doi-asserted-by":"crossref","first-page":"R5","DOI":"10.1152\/ajpregu.00440.2016","article-title":"Metabolic abnormalities and obesity's impact on the risk for developing preeclampsia","volume":"312","author":"Spradley","year":"2017","journal-title":"Am. J. Physiol. Regul. Integr. Comp. Physiol."},{"issue":"9499","key":"10.1016\/j.preghy.2018.06.005_b0090","doi-asserted-by":"crossref","first-page":"1797","DOI":"10.1016\/S0140-6736(05)67726-4","article-title":"Cardiovascular health after maternal placental syndromes (CHAMPS): population-based retrospective cohort study","volume":"366","author":"Ray","year":"2005","journal-title":"Lancet"},{"issue":"3","key":"10.1016\/j.preghy.2018.06.005_b0095","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1111\/jmwh.12469","article-title":"Preeclampsia and the risk of future vascular disease and mortality: a review","volume":"61","author":"Leslie","year":"2016","journal-title":"J. Midwifery Womens Health"},{"issue":"3","key":"10.1016\/j.preghy.2018.06.005_b0100","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1111\/ajo.12047","article-title":"The effects of an increasing gradient of maternal obesity on pregnancy outcomes","volume":"53","author":"Magann","year":"2013","journal-title":"Aust. N. Z. J. Obstet. Gynaecol."},{"issue":"6","key":"10.1016\/j.preghy.2018.06.005_b0105","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1097\/00000441-200512000-00004","article-title":"Epidemiology of the metabolic syndrome","volume":"330","author":"Reynolds","year":"2005","journal-title":"Am. J. Med. Sci."},{"key":"10.1016\/j.preghy.2018.06.005_b0110","doi-asserted-by":"crossref","first-page":"982","DOI":"10.1016\/j.ijcard.2015.11.109","article-title":"Metabolic syndrome in the non-pregnant state is associated with the development of preeclampsia","volume":"203","author":"Cho","year":"2016","journal-title":"Int. J. Cardiol."},{"issue":"2","key":"10.1016\/j.preghy.2018.06.005_b0115","first-page":"263","article-title":"The relationship between metabolic syndrome criteria and preeclampsia in primigravid women","volume":"20","author":"Kianpour","year":"2015","journal-title":"Iran. J. Nurs. Midwifery Res."},{"issue":"5","key":"10.1016\/j.preghy.2018.06.005_b0120","doi-asserted-by":"crossref","first-page":"938","DOI":"10.1161\/HYPERTENSIONAHA.115.05920","article-title":"Maternal obesity during pregnancy associates with premature mortality and major cardiovascular events in later life","volume":"66","author":"Lee","year":"2015","journal-title":"Hypertension"},{"issue":"20","key":"10.1016\/j.preghy.2018.06.005_b0125","doi-asserted-by":"crossref","first-page":"3066","DOI":"10.1161\/CIRCULATIONAHA.105.539528","article-title":"Metabolic syndrome as a precursor of cardiovascular disease and type 2 diabetes mellitus","volume":"112","author":"Wilson","year":"2005","journal-title":"Circulation"},{"issue":"6","key":"10.1016\/j.preghy.2018.06.005_b0130","doi-asserted-by":"crossref","first-page":"2318","DOI":"10.1210\/jc.2012-4253","article-title":"Metabolically healthy but obese, a matter of time? Findings from the prospective Pizarra study","volume":"98","author":"Soriguer","year":"2013","journal-title":"J. Clin. Endocrinol. Metab."},{"issue":"11","key":"10.1016\/j.preghy.2018.06.005_b0135","doi-asserted-by":"crossref","first-page":"1071","DOI":"10.1016\/j.jacc.2013.11.035","article-title":"Risk of myocardial infarction and heart failure among metabolically healthy but obese individuals: HUNT (Nord-Trondelag Health Study), Norway","volume":"63","author":"Morkedal","year":"2014","journal-title":"J. Am. Colloids Cardiol."},{"issue":"4","key":"10.1016\/j.preghy.2018.06.005_b0140","doi-asserted-by":"crossref","first-page":"1027","DOI":"10.1161\/HYPERTENSIONAHA.107.104646","article-title":"Mean arterial pressure at 11(+0) to 13(+6) weeks in the prediction of preeclampsia","volume":"51","author":"Poon","year":"2008","journal-title":"Hypertension"},{"issue":"5","key":"10.1016\/j.preghy.2018.06.005_b0145","doi-asserted-by":"crossref","first-page":"742","DOI":"10.1002\/uog.5157","article-title":"Uterine artery Doppler at 11 + 0 to 13 + 6 weeks in the prediction of pre-eclampsia","volume":"30","author":"Plasencia","year":"2007","journal-title":"Ultrasound Obstet. Gynecol."},{"issue":"1","key":"10.1016\/j.preghy.2018.06.005_b0150","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1080\/10790268.2009.11760755","article-title":"Pulse wave velocity for assessment of arterial stiffness among people with spinal cord injury: a pilot study","volume":"32","author":"Miyatani","year":"2009","journal-title":"J. Spinal Cord Med."},{"issue":"2","key":"10.1016\/j.preghy.2018.06.005_b0155","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1002\/pd.4519","article-title":"First trimester screening for early and late preeclampsia based on maternal characteristics, biophysical parameters, and angiogenic factors","volume":"35","author":"Crovetto","year":"2015","journal-title":"Prenat. Diagn."},{"issue":"1","key":"10.1016\/j.preghy.2018.06.005_b0160","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1007\/BF00788533","article-title":"Calculated mean arterial blood pressure in critically ill neonates","volume":"88","author":"Gevers","year":"1993","journal-title":"Basic Res. Cardiol."},{"issue":"4","key":"10.1016\/j.preghy.2018.06.005_b0165","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1046\/j.1469-0705.1992.02040261.x","article-title":"Color Doppler imaging of the uterine artery in pregnancy: normal ranges of impedance to blood flow, mean velocity and volume of flow","volume":"2","author":"Bower","year":"1992","journal-title":"Ultrasound Obstet. Gynecol."},{"key":"10.1016\/j.preghy.2018.06.005_b0170","article-title":"Assessing endothelial vasodilator function with the Endo-PAT 2000","volume":"44","author":"Axtell","year":"2010","journal-title":"J. Vis. Exp."},{"issue":"1","key":"10.1016\/j.preghy.2018.06.005_b0175","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1002\/uog.15893","article-title":"Endothelial dysfunction and vascular stiffness in women with previous pregnancy complicated by early or late pre-eclampsia","volume":"49","author":"Orabona","year":"2017","journal-title":"Ultrasound Obstet. Gynecol."},{"issue":"1","key":"10.1016\/j.preghy.2018.06.005_b0180","doi-asserted-by":"crossref","first-page":"23","DOI":"10.5830\/CVJA-2016-047","article-title":"Endothelial dysfunction and arterial stiffness in pre-eclampsia demonstrated by the EndoPAT method","volume":"28","author":"Meeme","year":"2017","journal-title":"Cardiovasc. J. Afr."},{"issue":"11","key":"10.1016\/j.preghy.2018.06.005_b0185","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1007\/s11906-014-0487-z","article-title":"Flow-mediated dilation: can new approaches provide greater mechanistic insight into vascular dysfunction in preeclampsia and other diseases?","volume":"16","author":"Weissgerber","year":"2014","journal-title":"Curr. Hypertens. Rep."},{"issue":"4","key":"10.1016\/j.preghy.2018.06.005_b0190","doi-asserted-by":"crossref","first-page":"554","DOI":"10.1161\/01.ATV.0000060460.52916.D6","article-title":"Noninvasive assessment of arterial stiffness and risk of atherosclerotic events","volume":"23","author":"Oliver","year":"2003","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"issue":"5","key":"10.1016\/j.preghy.2018.06.005_b0195","doi-asserted-by":"crossref","first-page":"532","DOI":"10.1053\/plac.2002.0944","article-title":"Expression of pregnancy-associated plasma protein-A (PAPP-A) during human villous trophoblast differentiation in vitro","volume":"24","author":"Guibourdenche","year":"2003","journal-title":"Placenta"},{"issue":"3","key":"10.1016\/j.preghy.2018.06.005_b0200","doi-asserted-by":"crossref","first-page":"576","DOI":"10.1172\/JCI107794","article-title":"Measurement of pregnancy-associated plasma proteins during human gestation","volume":"54","author":"Lin","year":"1974","journal-title":"J. Clin. Invest."},{"issue":"5","key":"10.1016\/j.preghy.2018.06.005_b0205","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1111\/j.1471-0528.1982.tb05078.x","article-title":"Amniotic fluid and plasma concentrations of pregnancy-associated plasma protein-A (PAPP-A) throughout pregnancy: comparison with other fetoplacental products","volume":"89","author":"Bischof","year":"1982","journal-title":"Br. J. Obstet. Gynaecol."},{"issue":"1","key":"10.1016\/j.preghy.2018.06.005_b0210","doi-asserted-by":"crossref","first-page":"5315","DOI":"10.1038\/s41598-017-04735-0","article-title":"Novel function of pregnancy-associated plasma protein A: promotes endometrium receptivity by up-regulating N-fucosylation","volume":"7","author":"Yu","year":"2017","journal-title":"Sci. Rep."},{"issue":"5","key":"10.1016\/j.preghy.2018.06.005_b0215","doi-asserted-by":"crossref","first-page":"2359","DOI":"10.1210\/jcem.87.5.8448","article-title":"Identification and regulation of the IGFBP-4 protease and its physiological inhibitor in human trophoblasts and endometrial stroma: evidence for paracrine regulation of IGF-II bioavailability in the placental bed during human implantation","volume":"87","author":"Giudice","year":"2002","journal-title":"J. Clin. Endocrinol. Metab."},{"issue":"1","key":"10.1016\/j.preghy.2018.06.005_b0220","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1081\/PRG-120016794","article-title":"Women with preeclampsia have increased serum levels of pregnancy-associated plasma protein A (PAPP-A), inhibin A, activin A and soluble E-selectin","volume":"22","author":"Bersinger","year":"2003","journal-title":"Hypertens. Pregnancy"},{"issue":"4","key":"10.1016\/j.preghy.2018.06.005_b0225","doi-asserted-by":"crossref","first-page":"1762","DOI":"10.1210\/jcem.87.4.8430","article-title":"Early pregnancy levels of pregnancy-associated plasma protein a and the risk of intrauterine growth restriction, premature birth, preeclampsia, and stillbirth","volume":"87","author":"Smith","year":"2002","journal-title":"J. Clin. Endocrinol. Metab."},{"issue":"7","key":"10.1016\/j.preghy.2018.06.005_b0230","doi-asserted-by":"crossref","first-page":"E295","DOI":"10.1503\/cmaj.110647","article-title":"Value of serum pregnancy-associated plasma protein A for predicting cardiovascular events among patients presenting with cardiac chest pain","volume":"185","author":"von Haehling","year":"2013","journal-title":"CMAJ"},{"issue":"20","key":"10.1016\/j.preghy.2018.06.005_b0235","doi-asserted-by":"crossref","first-page":"2093","DOI":"10.1093\/eurheartj\/ehi433","article-title":"Relationship among pregnancy associated plasma protein-A levels, clinical characteristics, and coronary artery disease extent in patients with chronic stable angina pectoris","volume":"26","author":"Cosin-Sales","year":"2005","journal-title":"Eur. Heart J."},{"issue":"6","key":"10.1016\/j.preghy.2018.06.005_b0240","doi-asserted-by":"crossref","first-page":"1065","DOI":"10.1111\/j.1432-1033.2004.04004.x","article-title":"Functional analyses of placental protein 13\/galectin-13","volume":"271","author":"Than","year":"2004","journal-title":"Eur. J. Biochem."},{"issue":"11","key":"10.1016\/j.preghy.2018.06.005_b0245","doi-asserted-by":"crossref","first-page":"875","DOI":"10.1093\/protein\/14.11.875","article-title":"Homology modelling and molecular dynamics studies of human placental tissue protein 13 (galectin-13)","volume":"14","author":"Visegrady","year":"2001","journal-title":"Protein Eng."},{"key":"10.1016\/j.preghy.2018.06.005_b0250","first-page":"1","article-title":"Maternal serum glycodelin levels in preeclampsia and its relationship with the severity of the disease","author":"Dundar","year":"2017","journal-title":"J. Matern Fetal Neonatal Med."},{"issue":"3","key":"10.1016\/j.preghy.2018.06.005_b0255","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1111\/aji.12471","article-title":"The pleiotropic effect of glycodelin-A in early pregnancy","volume":"75","author":"Lee","year":"2016","journal-title":"Am. J. Reprod. Immunol."},{"issue":"2","key":"10.1016\/j.preghy.2018.06.005_b0260","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1002\/uog.3876","article-title":"First-trimester maternal serum PP-13, PAPP-A and second-trimester uterine artery Doppler pulsatility index as markers of pre-eclampsia","volume":"29","author":"Spencer","year":"2007","journal-title":"Ultrasound Obstet. Gynecol."},{"issue":"9061","key":"10.1016\/j.preghy.2018.06.005_b0265","doi-asserted-by":"crossref","first-page":"1285","DOI":"10.1016\/S0140-6736(96)09264-1","article-title":"Activin A and inhibin A as possible endocrine markers for pre-eclampsia","volume":"349","author":"Muttukrishna","year":"1997","journal-title":"Lancet"},{"issue":"4","key":"10.1016\/j.preghy.2018.06.005_b0270","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1111\/j.1365-2265.1995.tb02648.x","article-title":"Measurement of serum concentrations of inhibin-A (alpha-beta A dimer) during human pregnancy","volume":"42","author":"Muttukrishna","year":"1995","journal-title":"Clin. Endocrinol. (Oxf.)"},{"issue":"9","key":"10.1016\/j.preghy.2018.06.005_b0275","first-page":"3328","article-title":"Changes in peripheral serum levels of total activin A during the human menstrual cycle and pregnancy","volume":"81","author":"Muttukrishna","year":"1996","journal-title":"J. Clin. Endocrinol. Metab."},{"issue":"8","key":"10.1016\/j.preghy.2018.06.005_b0280","doi-asserted-by":"crossref","first-page":"753","DOI":"10.1002\/pd.2279","article-title":"Maternal plasma inhibin A at 11\u201313 weeks of gestation in hypertensive disorders of pregnancy","volume":"29","author":"Akolekar","year":"2009","journal-title":"Prenat. Diagn."},{"issue":"3","key":"10.1016\/j.preghy.2018.06.005_b0285","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1159\/000235878","article-title":"Maternal serum activin a at 11\u201313 weeks of gestation in hypertensive disorders of pregnancy","volume":"25","author":"Akolekar","year":"2009","journal-title":"Fetal Diagn. Ther."},{"key":"10.1016\/j.preghy.2018.06.005_b0290","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1186\/1477-7827-8-102","article-title":"Biological functions of hCG and hCG-related molecules","volume":"8","author":"Cole","year":"2010","journal-title":"Reprod. Biol. Endocrinol."},{"issue":"7\u20138","key":"10.1016\/j.preghy.2018.06.005_b0295","first-page":"333","article-title":"Serum beta hCG levels and transvaginal echography in the early phases of pregnancy","volume":"45","author":"Giacomello","year":"1993","journal-title":"Minerva Ginecol."},{"issue":"7","key":"10.1016\/j.preghy.2018.06.005_b0300","first-page":"1001","article-title":"Serum beta human chorionic gonadotropin levels and preeclampsia","volume":"27","author":"Basirat","year":"2006","journal-title":"Saudi Med. J."},{"key":"10.1016\/j.preghy.2018.06.005_b0305","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3109\/00016347709156333","article-title":"Maternal serum alpha-feto-protein: its value in antenatal diagnosis of genetic disease and in obstetrical-gynaecological care","volume":"61","author":"Habib","year":"1977","journal-title":"Acta Obstet. Gynecol. Scand. Suppl."},{"key":"10.1016\/j.preghy.2018.06.005_b0310","doi-asserted-by":"crossref","first-page":"13","DOI":"10.4137\/CMRH.S21865","article-title":"Combination of PAPPA, fhCG\u03b2, AFP, PlGF, sTNFR1, and Maternal Characteristics in Prediction of Early-onset Preeclampsia","volume":"9","author":"Yliniemi","year":"2015","journal-title":"Clin. Med. Insights Reprod. Health"},{"issue":"1","key":"10.1016\/j.preghy.2018.06.005_b0315","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1055\/s-2007-1016248","article-title":"Endothelial dysfunction in preeclampsia","volume":"16","author":"Roberts","year":"1998","journal-title":"Semin. Reprod. Endocrinol."},{"issue":"19","key":"10.1016\/j.preghy.2018.06.005_b0320","doi-asserted-by":"crossref","first-page":"2121","DOI":"10.1161\/CIRCULATIONAHA.113.003215","article-title":"Diagnostic accuracy of placental growth factor in women with suspected preeclampsia: a prospective multicenter study","volume":"128","author":"Chappell","year":"2013","journal-title":"Circulation"},{"issue":"1","key":"10.1016\/j.preghy.2018.06.005_b0325","doi-asserted-by":"crossref","first-page":"103e1","DOI":"10.1016\/j.ajog.2015.08.034","article-title":"Competing risks model in screening for preeclampsia by maternal factors and biomarkers at 11-13 weeks gestation","volume":"214","author":"O'Gorman","year":"2016","journal-title":"Am. J. Obstet. Gynecol."},{"issue":"2","key":"10.1016\/j.preghy.2018.06.005_b0330","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1016\/j.ijgo.2004.10.005","article-title":"Angiogenin and vascular endothelial growth factor in pregnancies complicated by preeclampsia","volume":"88","author":"Shaarawy","year":"2005","journal-title":"Int. J. Gynaecol. Obstet."},{"issue":"7","key":"10.1016\/j.preghy.2018.06.005_b0335","doi-asserted-by":"crossref","first-page":"778","DOI":"10.1111\/j.1471-0528.2012.03311.x","article-title":"Accuracy of circulating placental growth factor, vascular endothelial growth factor, soluble fms-like tyrosine kinase 1 and soluble endoglin in the prediction of pre-eclampsia: a systematic review and meta-analysis","volume":"119","author":"Kleinrouweler","year":"2012","journal-title":"BJOG"},{"issue":"5","key":"10.1016\/j.preghy.2018.06.005_b0340","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1172\/JCI17189","article-title":"Excess placental soluble fms-like tyrosine kinase 1 (sFlt1) may contribute to endothelial dysfunction, hypertension, and proteinuria in preeclampsia","volume":"111","author":"Maynard","year":"2003","journal-title":"J. Clin. Invest."},{"issue":"4","key":"10.1016\/j.preghy.2018.06.005_b0345","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1038\/jhh.2011.29","article-title":"The relationship between circulating endothelin-1, soluble fms-like tyrosine kinase-1 and soluble endoglin in preeclampsia","volume":"26","author":"Aggarwal","year":"2012","journal-title":"J. Hum. Hypertens."},{"key":"10.1016\/j.preghy.2018.06.005_b0350","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1186\/1472-6793-12-4","article-title":"Obesity-associated insulin resistance is correlated to adipose tissue vascular endothelial growth factors and metalloproteinase levels","volume":"12","author":"Tinahones","year":"2012","journal-title":"BMC Physiol."},{"issue":"1","key":"10.1016\/j.preghy.2018.06.005_b0355","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1161\/ATVBAHA.108.171066","article-title":"Potential role for plasma placental growth factor in predicting coronary heart disease risk in women","volume":"29","author":"Cassidy","year":"2009","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"issue":"5","key":"10.1016\/j.preghy.2018.06.005_b0360","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1080\/00365513.2016.1190863","article-title":"Sflt-1 in heart failure: relation with disease severity and biomarkers","volume":"76","author":"Gruson","year":"2016","journal-title":"Scand. J. Clin. Lab. Invest."},{"issue":"1","key":"10.1016\/j.preghy.2018.06.005_b0365","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1016\/j.atherosclerosis.2014.12.061","article-title":"Plasma endothelin-1 and cardiovascular risk among young and healthy adults","volume":"239","author":"Bossard","year":"2015","journal-title":"Atherosclerosis"},{"issue":"1","key":"10.1016\/j.preghy.2018.06.005_b0370","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1080\/10641950802233064","article-title":"Interactions between inflammatory and oxidative stress in preeclampsia","volume":"28","author":"Ouyang","year":"2009","journal-title":"Hypertens. Pregnancy"},{"issue":"7","key":"10.1016\/j.preghy.2018.06.005_b0375","doi-asserted-by":"crossref","first-page":"518","DOI":"10.1016\/j.jsgi.2005.06.007","article-title":"Absence of in vivo generalized pro-inflammatory endothelial activation in severe, early-onset preeclampsia","volume":"12","author":"Donker","year":"2005","journal-title":"J. Soc. Gynecol. Invest."},{"issue":"2","key":"10.1016\/j.preghy.2018.06.005_b0380","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1080\/10641950802601179","article-title":"Association of maternal serum CRP, IL-6, TNF-alpha, homocysteine, folic acid and vitamin B12 levels with the severity of preeclampsia and fetal birth weight","volume":"28","author":"Guven","year":"2009","journal-title":"Hypertens. Pregnancy"},{"issue":"6","key":"10.1016\/j.preghy.2018.06.005_b0385","doi-asserted-by":"crossref","first-page":"1233","DOI":"10.1097\/AOG.0b013e3181dd5137","article-title":"Early-pregnancy multiple serum markers and second-trimester uterine artery Doppler in predicting preeclampsia","volume":"115","author":"Thilaganathan","year":"2010","journal-title":"Obstet. Gynecol."},{"issue":"1","key":"10.1016\/j.preghy.2018.06.005_b0390","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/S0165-0378(02)00085-2","article-title":"Elevated C-reactive protein levels during first trimester of pregnancy are indicative of preeclampsia and intrauterine growth restriction","volume":"59","author":"Tjoa","year":"2003","journal-title":"J. Reprod. Immunol."},{"issue":"2","key":"10.1016\/j.preghy.2018.06.005_b0395","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1016\/S0301-2115(01)00484-5","article-title":"Predictive value of tumor necrosis factor alpha (TNF-alpha) in preeclampsia","volume":"100","author":"Serin","year":"2002","journal-title":"Eur. J. Obstet. Gynecol. Reprod. Biol."},{"issue":"10","key":"10.1016\/j.preghy.2018.06.005_b0400","doi-asserted-by":"crossref","first-page":"E1610","DOI":"10.1210\/jc.2013-2038","article-title":"Does inflammation determine metabolic health status in obese and nonobese adults?","volume":"98","author":"Phillips","year":"2013","journal-title":"J. Clin. Endocrinol. Metab."},{"issue":"4","key":"10.1016\/j.preghy.2018.06.005_b0405","doi-asserted-by":"crossref","first-page":"426","DOI":"10.1038\/ejcn.2011.170","article-title":"The association between inflammatory biomarkers and metabolically healthy obesity depends of the definition used","volume":"66","author":"Marques-Vidal","year":"2012","journal-title":"Eur. J. Clin. Nutr."},{"issue":"12","key":"10.1016\/j.preghy.2018.06.005_b0410","doi-asserted-by":"crossref","first-page":"836","DOI":"10.1056\/NEJM200003233421202","article-title":"C-reactive protein and other markers of inflammation in the prediction of cardiovascular disease in women","volume":"342","author":"Ridker","year":"2000","journal-title":"N. Engl. J. Med."},{"issue":"12","key":"10.1016\/j.preghy.2018.06.005_b0415","first-page":"15919","article-title":"PAI-1 and TNF-\u03b1 profiles of adipose tissue in obese cardiovascular disease patients","volume":"8","author":"Bilgic Gazioglu","year":"2015","journal-title":"Int. J. Clin. Exp. Pathol."},{"issue":"8","key":"10.1016\/j.preghy.2018.06.005_b0420","doi-asserted-by":"crossref","first-page":"880","DOI":"10.3109\/14767051003774942","article-title":"Maternal and umbilical serum levels of interleukin-6, interleukin-8, and tumor necrosis factor-alpha in normal pregnancies and in pregnancies complicated by preeclampsia","volume":"23","author":"Tosun","year":"2010","journal-title":"J. Matern Fetal Neonatal Med."},{"key":"10.1016\/j.preghy.2018.06.005_b0425","doi-asserted-by":"crossref","DOI":"10.1097\/HJH.0000000000001461","article-title":"Serum podocalyxin is significantly increased in early-onset preeclampsia and may represent a novel marker of maternal endothelial cell dysfunction","author":"Chen","year":"2017","journal-title":"J. Hypertens."},{"issue":"1","key":"10.1016\/j.preghy.2018.06.005_b0430","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1042\/BJ20100285","article-title":"The obese healthy paradox: is inflammation the answer?","volume":"430","author":"Barbarroja","year":"2010","journal-title":"Biochem. J."},{"issue":"1","key":"10.1016\/j.preghy.2018.06.005_b0435","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1016\/j.ajog.2004.11.055","article-title":"Calprotectin, a marker of inflammation, is elevated in the maternal but not in the fetal circulation in preeclampsia","volume":"193","author":"Braekke","year":"2005","journal-title":"Am. J. Obstet. Gynecol."},{"issue":"3","key":"10.1016\/j.preghy.2018.06.005_b0440","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1002\/ijgo.12142","article-title":"Maternal circulating levels of transforming growth factor-beta superfamily and its soluble receptors in hypertensive disorders of pregnancy","volume":"137","author":"Xu","year":"2017","journal-title":"Int. J. Gynaecol. Obstet."},{"issue":"2","key":"10.1016\/j.preghy.2018.06.005_b0445","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1016\/j.jri.2012.02.006","article-title":"Promoter region polymorphisms in the transforming growth factor beta-1 (TGFbeta1) gene and serum TGFbeta1 concentration in preeclamptic and control Iranian women","volume":"94","author":"Feizollahzadeh","year":"2012","journal-title":"J. Reprod. Immunol."},{"issue":"4","key":"10.1016\/j.preghy.2018.06.005_b0450","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1177\/1933719114529372","article-title":"Follistatin-like 3 across gestation in preeclampsia and uncomplicated pregnancies among lean and obese women","volume":"22","author":"Founds","year":"2015","journal-title":"Reprod. Sci."},{"issue":"3","key":"10.1016\/j.preghy.2018.06.005_b0455","doi-asserted-by":"crossref","first-page":"361.e1","DOI":"10.1016\/j.ajog.2016.03.020","article-title":"Decorin over-expression by decidual cells in preeclampsia: a potential blood biomarker","volume":"215","author":"Siddiqui","year":"2016","journal-title":"Am. J. Obstet. Gynecol."},{"issue":"24","key":"10.1016\/j.preghy.2018.06.005_b0460","doi-asserted-by":"crossref","first-page":"4059","DOI":"10.3109\/14767058.2016.1154942","article-title":"Placental levels of total oxidative and anti-oxidative status, ADAMTS-12 and decorin in early- and late-onset severe preeclampsia","volume":"29","author":"Daglar","year":"2016","journal-title":"J. Matern Fetal Neonatal Med."},{"issue":"5","key":"10.1016\/j.preghy.2018.06.005_b0465","doi-asserted-by":"crossref","first-page":"688","DOI":"10.3346\/jkms.2004.19.5.688","article-title":"Maternal serum levels of VCAM-1, ICAM-1 and E-selectin in preeclampsia","volume":"19","author":"Kim","year":"2004","journal-title":"J. Korean Med. Sci."},{"issue":"7","key":"10.1016\/j.preghy.2018.06.005_b0470","doi-asserted-by":"crossref","first-page":"1482","DOI":"10.1038\/oby.2010.332","article-title":"Body size phenotypes and inflammation in the Women's Health Initiative Observational Study","volume":"19","author":"Wildman","year":"2011","journal-title":"Obesity (Silver Spring)"},{"issue":"1","key":"10.1016\/j.preghy.2018.06.005_b0475","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1111\/j.1538-7836.2005.01678.x","article-title":"Soluble intracellular adhesion molecule-1 is associated with cardiovascular disease risk and mortality in older adults","volume":"4","author":"Jenny","year":"2006","journal-title":"J. Thromb. Haemost."},{"issue":"12","key":"10.1016\/j.preghy.2018.06.005_b0480","doi-asserted-by":"crossref","first-page":"4219","DOI":"10.1161\/01.CIR.96.12.4219","article-title":"Circulating adhesion molecules VCAM-1, ICAM-1, and E-selectin in carotid atherosclerosis and incident coronary heart disease cases: the Atherosclerosis Risk In Communities (ARIC) study","volume":"96","author":"Hwang","year":"1997","journal-title":"Circulation"},{"issue":"1","key":"10.1016\/j.preghy.2018.06.005_b0485","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1074\/jbc.273.1.157","article-title":"A novel, secreted form of human ADAM 12 (meltrin alpha) provokes myogenesis in vivo","volume":"273","author":"Gilpin","year":"1998","journal-title":"J. Biol. Chem."},{"issue":"3","key":"10.1016\/j.preghy.2018.06.005_b0490","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1002\/pd.1957","article-title":"ADAM12s in maternal serum as a potential marker of pre-eclampsia","volume":"28","author":"Spencer","year":"2008","journal-title":"Prenat. Diagn."},{"issue":"4","key":"10.1016\/j.preghy.2018.06.005_b0495","doi-asserted-by":"crossref","first-page":"442","DOI":"10.3109\/10641955.2012.690059","article-title":"Metalloprotease (ADAM12-S) as a predictor of preeclampsia: correlation with severity, maternal complications, fetal outcome, and Doppler parameters","volume":"31","author":"El-Sherbiny","year":"2012","journal-title":"Hypertens. Pregnancy"},{"issue":"1","key":"10.1016\/j.preghy.2018.06.005_b0500","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1097\/01.AOG.0000165829.65319.65","article-title":"Reduction of the disintegrin and metalloprotease ADAM12 in preeclampsia","volume":"106","author":"Laigaard","year":"2005","journal-title":"Obstet. Gynecol."},{"issue":"4","key":"10.1016\/j.preghy.2018.06.005_b0505","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1016\/j.jjcc.2013.11.006","article-title":"Adipokines: a link between obesity and cardiovascular disease","volume":"63","author":"Nakamura","year":"2014","journal-title":"J. Cardiol."},{"issue":"1","key":"10.1016\/j.preghy.2018.06.005_b0510","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/j.atherosclerosis.2006.03.003","article-title":"Leptin and atherosclerosis","volume":"189","author":"Beltowski","year":"2006","journal-title":"Atherosclerosis"},{"issue":"2","key":"10.1016\/j.preghy.2018.06.005_b0515","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1016\/S0026-0495(00)91559-2","article-title":"Leptin during and after preeclamptic or normal pregnancy: its relation to serum insulin and insulin sensitivity","volume":"49","author":"Laivuori","year":"2000","journal-title":"Metabolism"},{"issue":"2","key":"10.1016\/j.preghy.2018.06.005_b0520","doi-asserted-by":"crossref","first-page":"E326","DOI":"10.1152\/ajpendo.00020.2005","article-title":"Increased plasma levels of adipokines in preeclampsia: relationship to placenta and adipose tissue gene expression","volume":"290","author":"Haugen","year":"2006","journal-title":"Am. J. Physiol. Endocrinol. Metab."},{"issue":"12","key":"10.1016\/j.preghy.2018.06.005_b0525","first-page":"1272","article-title":"The relationships between leptin and inflammatory cytokines in women with pre-eclampsia","volume":"108","author":"Bartha","year":"2001","journal-title":"BJOG"},{"issue":"1","key":"10.1016\/j.preghy.2018.06.005_b0530","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1111\/j.1600-0897.2007.00486.x","article-title":"Leptin, IL-10 and inflammatory markers (TNF-alpha, IL-6 and IL-8) in pre-eclamptic, normotensive pregnant and healthy non-pregnant women","volume":"58","author":"Sharma","year":"2007","journal-title":"Am. J. Reprod. Immunol."},{"issue":"6","key":"10.1016\/j.preghy.2018.06.005_b0535","doi-asserted-by":"crossref","first-page":"1317","DOI":"10.1007\/s00404-013-2915-8","article-title":"Maternal serum leptin as a marker of preeclampsia","volume":"288","author":"El Shahat","year":"2013","journal-title":"Arch. Gynecol. Obstet."},{"issue":"3 Pt 2","key":"10.1016\/j.preghy.2018.06.005_b0540","doi-asserted-by":"crossref","first-page":"979","DOI":"10.1016\/j.ajog.2005.06.041","article-title":"The levels of leptin, adiponectin, and resistin in normal weight, overweight, and obese pregnant women with and without preeclampsia","volume":"193","author":"Hendler","year":"2005","journal-title":"Am. J. Obstet. Gynecol."},{"issue":"4","key":"10.1016\/j.preghy.2018.06.005_b0545","doi-asserted-by":"crossref","first-page":"165","DOI":"10.14712\/18059694.2015.41","article-title":"Hyperleptinemia as a prognostic factor for preeclampsia: a cohort study","volume":"55","author":"Mendieta Zeron","year":"2012","journal-title":"Acta Medica (Hradec Kralove)"},{"key":"10.1016\/j.preghy.2018.06.005_b0550","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1016\/j.appet.2016.11.013","article-title":"Leptin as a cardiovascular risk marker in metabolically healthy obese: hyperleptinemia in metabolically healthy obese","volume":"108","author":"Jamar","year":"2017","journal-title":"Appetite"},{"issue":"10","key":"10.1016\/j.preghy.2018.06.005_b0555","doi-asserted-by":"crossref","first-page":"e410","DOI":"10.1111\/ijd.12340","article-title":"Serum leptin, adiponectin, and resistin among adult patients with acanthosis nigricans: correlations with insulin resistance and risk factors for cardiovascular disease","volume":"53","author":"Atwa","year":"2014","journal-title":"Int. J. Dermatol."},{"issue":"1","key":"10.1016\/j.preghy.2018.06.005_b0560","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1016\/j.preghy.2010.10.013","article-title":"The role of obesity in preeclampsia","volume":"1","author":"Roberts","year":"2011","journal-title":"Pregnancy Hypertens."},{"issue":"2","key":"10.1016\/j.preghy.2018.06.005_b0565","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1530\/EJE-07-0454","article-title":"Circulating high-molecular-weight adiponectin is upregulated in preeclampsia and is related to insulin sensitivity and renal function","volume":"158","author":"Fasshauer","year":"2008","journal-title":"Eur. J. Endocrinol."},{"issue":"6","key":"10.1016\/j.preghy.2018.06.005_b0570","doi-asserted-by":"crossref","first-page":"584","DOI":"10.1177\/1933719109332828","article-title":"Circulating and uteroplacental adipocytokine concentrations in preeclampsia","volume":"16","author":"Herse","year":"2009","journal-title":"Reprod. Sci."},{"issue":"4","key":"10.1016\/j.preghy.2018.06.005_b0575","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1515\/JPM.2009.085","article-title":"Maternal serum adiponectin multimers in preeclampsia","volume":"37","author":"Mazaki-Tovi","year":"2009","journal-title":"J. Perinat. Med."},{"issue":"10","key":"10.1016\/j.preghy.2018.06.005_b0580","doi-asserted-by":"crossref","first-page":"4075","DOI":"10.1210\/jc.2007-2724","article-title":"High adiponectin concentrations are associated with the metabolically healthy obese phenotype","volume":"93","author":"Aguilar-Salinas","year":"2008","journal-title":"J. Clin. Endocrinol. Metab."},{"issue":"1","key":"10.1016\/j.preghy.2018.06.005_b0585","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1161\/01.ATV.0000048856.22331.50","article-title":"Association of hypoadiponectinemia with coronary artery disease in men","volume":"23","author":"Kumada","year":"2003","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"issue":"1","key":"10.1016\/j.preghy.2018.06.005_b0590","first-page":"18","article-title":"Leptin to adiponectin ratio in preeclampsia, Bangladesh","volume":"39","author":"Khosrowbeygi","year":"2013","journal-title":"Med. Res. Counc. Bull."},{"issue":"4","key":"10.1016\/j.preghy.2018.06.005_b0595","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1038\/jhh.2012.10","article-title":"Maternal serum visfatin at 11\u201313 weeks' gestation in preeclampsia","volume":"27","author":"Ferreira","year":"2013","journal-title":"J. Hum. Hypertens."},{"issue":"9","key":"10.1016\/j.preghy.2018.06.005_b0600","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1007\/BF03346661","article-title":"Serum levels of the adipokine lipocalin-2 are increased in preeclampsia","volume":"33","author":"Stepan","year":"2010","journal-title":"J. Endocrinol. Invest."},{"issue":"6","key":"10.1016\/j.preghy.2018.06.005_b0605","first-page":"418","article-title":"Correlation of lipocalin-2 and its receptor expressions with preeclampsia","volume":"47","author":"Cao","year":"2012","journal-title":"Zhonghua Fu Chan Ke Za Zhi"},{"issue":"12","key":"10.1016\/j.preghy.2018.06.005_b0610","doi-asserted-by":"crossref","first-page":"807","DOI":"10.1097\/01.ogx.0000193879.79268.59","article-title":"The role of placental oxidative stress and lipid peroxidation in preeclampsia","volume":"60","author":"Gupta","year":"2005","journal-title":"Obstet. Gynecol. Surv."},{"issue":"6","key":"10.1016\/j.preghy.2018.06.005_b0615","doi-asserted-by":"crossref","first-page":"1367","DOI":"10.1007\/s00404-011-1865-2","article-title":"Evaluation of oxidative stress markers in first trimester for assessment of preeclampsia risk","volume":"284","author":"Genc","year":"2011","journal-title":"Arch. Gynecol. Obstet."},{"key":"10.1016\/j.preghy.2018.06.005_b0620","doi-asserted-by":"crossref","first-page":"627","DOI":"10.2147\/IJWH.S117850","article-title":"Comparison of lipid profile parameters and oxidized low-density lipoprotein between normal and preeclamptic pregnancies in a tertiary care hospital in Nepal","volume":"8","author":"Timalsina","year":"2016","journal-title":"Int. J. Womens Health"},{"issue":"4","key":"10.1016\/j.preghy.2018.06.005_b0625","doi-asserted-by":"crossref","first-page":"554","DOI":"10.1016\/j.metabol.2012.10.006","article-title":"Increased oxidative stress in normal-weight postmenopausal women with metabolic syndrome compared with metabolically healthy overweight\/obese individuals","volume":"62","author":"Kim","year":"2013","journal-title":"Metabolism"},{"issue":"15","key":"10.1016\/j.preghy.2018.06.005_b0630","doi-asserted-by":"crossref","first-page":"1487","DOI":"10.1161\/01.CIR.98.15.1487","article-title":"Oxidized LDL and malondialdehyde-modified LDL in patients with acute coronary syndromes and stable coronary artery disease","volume":"98","author":"Holvoet","year":"1998","journal-title":"Circulation"},{"issue":"3","key":"10.1016\/j.preghy.2018.06.005_b0635","first-page":"178","article-title":"The role of apoptosis in preeclampsia","volume":"7","author":"Levy","year":"2005","journal-title":"Isr. Med. Assoc. J."},{"issue":"3","key":"10.1016\/j.preghy.2018.06.005_b0640","doi-asserted-by":"crossref","first-page":"245","DOI":"10.3109\/10641955.2013.796969","article-title":"The role of apoptosis on trophoblast cell invasion in the placental bed of normotensive and preeclamptic pregnancies","volume":"32","author":"Naicker","year":"2013","journal-title":"Hypertens. Pregnancy"},{"issue":"11","key":"10.1016\/j.preghy.2018.06.005_b0645","doi-asserted-by":"crossref","first-page":"1170","DOI":"10.1177\/0960327112472998","article-title":"Pathogenesis of preeclampsia: Implications of apoptotic markers and oxidative stress","volume":"32","author":"Shaker","year":"2013","journal-title":"Hum. Exp. Toxicol."},{"issue":"2","key":"10.1016\/j.preghy.2018.06.005_b0650","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1161\/01.CIR.95.2.320","article-title":"Apoptosis in human acute myocardial infarction","volume":"95","author":"Saraste","year":"1997","journal-title":"Circulation"},{"issue":"5","key":"10.1016\/j.preghy.2018.06.005_b0655","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1016\/j.diabet.2014.02.007","article-title":"Differences in vitamin D concentration between metabolically healthy and unhealthy obese adults: associations with inflammatory and cardiometabolic markers in 4391 subjects","volume":"40","author":"Esteghamati","year":"2014","journal-title":"Diabetes Metab."},{"issue":"2","key":"10.1016\/j.preghy.2018.06.005_b0660","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1097\/EDE.0000000000000039","article-title":"Maternal vitamin D status and the risk of mild and severe preeclampsia","volume":"25","author":"Bodnar","year":"2014","journal-title":"Epidemiology"},{"issue":"4","key":"10.1016\/j.preghy.2018.06.005_b0665","doi-asserted-by":"crossref","DOI":"10.1016\/j.ajog.2014.11.009","article-title":"Vitamin D status in early pregnancy and risk of preeclampsia","volume":"212","author":"Achkar","year":"2015","journal-title":"Am. J. Obstet. Gynecol."},{"issue":"6","key":"10.1016\/j.preghy.2018.06.005_b0670","doi-asserted-by":"crossref","first-page":"1247","DOI":"10.1007\/s00404-014-3550-8","article-title":"Relationship between preeclampsia and vitamin D deficiency: a case control study","volume":"291","author":"Singla","year":"2015","journal-title":"Arch. Gynecol. Obstet."},{"issue":"4","key":"10.1016\/j.preghy.2018.06.005_b0675","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1161\/CIRCULATIONAHA.107.706127","article-title":"Vitamin D deficiency and risk of cardiovascular disease","volume":"117","author":"Wang","year":"2008","journal-title":"Circulation"},{"issue":"6","key":"10.1016\/j.preghy.2018.06.005_b0680","first-page":"462","article-title":"Serum uric acid levels and risk of developing preeclampsia","volume":"74","author":"Corominas","year":"2014","journal-title":"Medicina (B Aires)"},{"issue":"14","key":"10.1016\/j.preghy.2018.06.005_b0685","doi-asserted-by":"crossref","first-page":"1546","DOI":"10.1001\/archinte.164.14.1546","article-title":"Uric acid level as a risk factor for cardiovascular and all-cause mortality in middle-aged men: a prospective cohort study","volume":"164","author":"Niskanen","year":"2004","journal-title":"Arch. Intern. Med."},{"issue":"1","key":"10.1016\/j.preghy.2018.06.005_b0690","doi-asserted-by":"crossref","first-page":"E71","DOI":"10.1002\/oby.20061","article-title":"Uric acid best predicts metabolically unhealthy obesity with increased cardiovascular risk in youth and adults","volume":"21","author":"Mangge","year":"2013","journal-title":"Obesity (Silver Spring)"},{"issue":"3","key":"10.1016\/j.preghy.2018.06.005_b0695","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1007\/s12291-014-0455-z","article-title":"Metabolomics: a tool ahead for understanding molecular mechanisms of drugs and diseases","volume":"30","author":"Shah","year":"2015","journal-title":"Indian J. Clin. Biochem."},{"key":"10.1016\/j.preghy.2018.06.005_b0700","first-page":"354671","article-title":"Metabolomics for biomarker discovery: moving to the clinic","volume":"2015","author":"Zhang","year":"2015","journal-title":"Biomed. Res. Int."},{"issue":"10","key":"10.1016\/j.preghy.2018.06.005_b0705","doi-asserted-by":"crossref","first-page":"1840","DOI":"10.3109\/14767058.2012.680254","article-title":"Metabolomics and first-trimester prediction of early-onset preeclampsia","volume":"25","author":"Bahado-Singh","year":"2012","journal-title":"J. Matern Fetal Neonatal Med."},{"issue":"12","key":"10.1016\/j.preghy.2018.06.005_b0710","doi-asserted-by":"crossref","first-page":"1455","DOI":"10.1016\/j.placenta.2015.10.019","article-title":"Metabolic profiles of placenta in preeclampsia using HR-MAS MRS metabolomics","volume":"36","author":"Austdal","year":"2015","journal-title":"Placenta"},{"issue":"10","key":"10.1016\/j.preghy.2018.06.005_b0715","doi-asserted-by":"crossref","first-page":"990","DOI":"10.1002\/pd.2822","article-title":"First-trimester prediction of preeclampsia using metabolomic biomarkers: a discovery phase study","volume":"31","author":"Odibo","year":"2011","journal-title":"Prenat. Diagn."},{"issue":"5","key":"10.1016\/j.preghy.2018.06.005_b0720","doi-asserted-by":"crossref","first-page":"e98540","DOI":"10.1371\/journal.pone.0098540","article-title":"Metabolomics profiling for identification of novel potential markers in early prediction of preeclampsia","volume":"9","author":"Kuc","year":"2014","journal-title":"PLoS One"},{"issue":"2","key":"10.1016\/j.preghy.2018.06.005_b0725","doi-asserted-by":"crossref","first-page":"326","DOI":"10.1373\/clinchem.2007.097469","article-title":"Effect of homocysteine concentration in early pregnancy on gestational hypertensive disorders and other pregnancy outcomes","volume":"54","author":"Dodds","year":"2008","journal-title":"Clin. Chem."},{"key":"10.1016\/j.preghy.2018.06.005_b0730","doi-asserted-by":"crossref","DOI":"10.1007\/s00404-017-4457-y","article-title":"Maternal serum homocysteine and uterine artery Doppler as predictors of preeclampsia and poor placentation","author":"Maged","year":"2017","journal-title":"Arch. Gynecol. Obstet."},{"issue":"5 Pt 1","key":"10.1016\/j.preghy.2018.06.005_b0735","doi-asserted-by":"crossref","first-page":"876","DOI":"10.1097\/01.AOG.0000125699.60416.03","article-title":"Increased plasma carnitine concentrations in preeclampsia","volume":"103","author":"Thiele","year":"2004","journal-title":"Obstet. Gynecol."},{"key":"10.1016\/j.preghy.2018.06.005_b0740","doi-asserted-by":"crossref","first-page":"857108","DOI":"10.1155\/2015\/857108","article-title":"First-trimester serum acylcarnitine levels to predict preeclampsia: a metabolomics approach","volume":"2015","author":"Koster","year":"2015","journal-title":"Dis. Markers"},{"issue":"4","key":"10.1016\/j.preghy.2018.06.005_b0745","doi-asserted-by":"crossref","first-page":"e93148","DOI":"10.1371\/journal.pone.0093148","article-title":"Metabolic signatures of cultured human adipocytes from metabolically healthy versus unhealthy obese individuals","volume":"9","author":"B\u00f6hm","year":"2014","journal-title":"PLoS One"},{"issue":"6","key":"10.1016\/j.preghy.2018.06.005_b0750","doi-asserted-by":"crossref","DOI":"10.3390\/nu8060324","article-title":"Association between metabolite profiles, metabolic syndrome and obesity status","volume":"8","author":"Allam-Ndoul","year":"2016","journal-title":"Nutrients"},{"issue":"7","key":"10.1016\/j.preghy.2018.06.005_b0755","doi-asserted-by":"crossref","first-page":"3455","DOI":"10.1021\/pr500416v","article-title":"Serum and adipose tissue amino acid homeostasis in the metabolically healthy obese","volume":"13","author":"Badoud","year":"2014","journal-title":"J. Proteome Res."},{"issue":"2","key":"10.1016\/j.preghy.2018.06.005_b0760","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1016\/j.atherosclerosis.2013.10.029","article-title":"Metabolomics signature improves the prediction of cardiovascular events in elderly subjects","volume":"232","author":"Rizza","year":"2014","journal-title":"Atherosclerosis"},{"issue":"2","key":"10.1016\/j.preghy.2018.06.005_b0765","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1161\/CIRCGENETICS.109.852814","article-title":"Association of a peripheral blood metabolic profile with coronary artery disease and risk of subsequent cardiovascular events","volume":"3","author":"Shah","year":"2010","journal-title":"Circ. Cardiovasc. Genet."},{"issue":"26","key":"10.1016\/j.preghy.2018.06.005_b0770","doi-asserted-by":"crossref","first-page":"1982","DOI":"10.1093\/eurheartj\/ehs424","article-title":"A diabetes-predictive amino acid score and future cardiovascular disease","volume":"34","author":"Magnusson","year":"2013","journal-title":"Eur. Heart J."},{"issue":"10","key":"10.1016\/j.preghy.2018.06.005_b0775","doi-asserted-by":"crossref","first-page":"1025","DOI":"10.1016\/j.jacc.2011.05.028","article-title":"Homocysteine and reclassification of cardiovascular disease risk","volume":"58","author":"Veeranna","year":"2011","journal-title":"J. Am. Colloids Cardiol."},{"issue":"2","key":"10.1016\/j.preghy.2018.06.005_b0780","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1590\/S1516-31802011000200004","article-title":"Serum lipid levels in pregnancies complicated by preeclampsia","volume":"129","author":"Lima","year":"2011","journal-title":"Sao Paulo Med. J."},{"issue":"7","key":"10.1016\/j.preghy.2018.06.005_b0785","doi-asserted-by":"crossref","first-page":"4145","DOI":"10.1210\/jc.2005-0482","article-title":"The metabolically healthy but obese individual presents a favorable inflammation profile","volume":"90","author":"Karelis","year":"2005","journal-title":"J. Clin. Endocrinol. Metab."},{"issue":"3","key":"10.1016\/j.preghy.2018.06.005_b0790","first-page":"1020","article-title":"What are the physical characteristics associated with a normal metabolic profile despite a high level of obesity in postmenopausal women?","volume":"86","author":"Brochu","year":"2001","journal-title":"J. Clin. Endocrinol. Metab."},{"issue":"2","key":"10.1016\/j.preghy.2018.06.005_b0795","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1016\/S0021-9150(00)00603-1","article-title":"HDL-cholesterol as a marker of coronary heart disease risk: the Qu\u00e9bec cardiovascular study","volume":"153","author":"Despr\u00e9s","year":"2000","journal-title":"Atherosclerosis"},{"issue":"14","key":"10.1016\/j.preghy.2018.06.005_b0800","doi-asserted-by":"crossref","first-page":"1179","DOI":"10.1016\/S0002-9149(96)00159-2","article-title":"Hypertriglyceridemia and elevated lipoprotein(a) are risk factors for major coronary events in middle-aged men","volume":"77","author":"Assmann","year":"1996","journal-title":"Am. J. Cardiol."},{"issue":"10","key":"10.1016\/j.preghy.2018.06.005_b0805","doi-asserted-by":"crossref","first-page":"851","DOI":"10.1002\/pd.708","article-title":"Maternal weight correction of maternal serum PAPP-A and free beta-hCG MoM when screening for trisomy 21 in the first trimester of pregnancy","volume":"23","author":"Spencer","year":"2003","journal-title":"Prenat. Diagn."},{"issue":"7","key":"10.1016\/j.preghy.2018.06.005_b0810","doi-asserted-by":"crossref","first-page":"933","DOI":"10.1586\/erc.12.74","article-title":"Obesity and metabolic syndrome as related to cardiovascular disease","volume":"10","author":"Nikolopoulou","year":"2012","journal-title":"Expert Rev. Cardiovasc. Ther."},{"issue":"7","key":"10.1016\/j.preghy.2018.06.005_b0815","doi-asserted-by":"crossref","first-page":"877","DOI":"10.1002\/uog.6124","article-title":"Prediction of pre-eclampsia by a combination of maternal history, uterine artery Doppler and mean arterial pressure","volume":"32","author":"Onwudiwe","year":"2008","journal-title":"Ultrasound Obstet. Gynecol."},{"issue":"1","key":"10.1016\/j.preghy.2018.06.005_b0820","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1159\/000341264","article-title":"Competing risks model in early screening for preeclampsia by biophysical and biochemical markers","volume":"33","author":"Akolekar","year":"2013","journal-title":"Fetal Diagn. Ther."},{"issue":"1","key":"10.1016\/j.preghy.2018.06.005_b0825","doi-asserted-by":"crossref","first-page":"93","DOI":"10.3109\/10641955.2010.484086","article-title":"Hypertensive disorders in pregnancy: screening by systolic diastolic and mean arterial pressure at 11\u201313 weeks","volume":"30","author":"Poon","year":"2011","journal-title":"Hypertens. Pregnancy"},{"issue":"5","key":"10.1016\/j.preghy.2018.06.005_b0830","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1016\/j.amjhyper.2006.12.012","article-title":"First-trimester mean arterial pressure and risk of preeclampsia","volume":"20","author":"Miller","year":"2007","journal-title":"Am. J. Hypertens."},{"issue":"6","key":"10.1016\/j.preghy.2018.06.005_b0835","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1002\/uog.7559","article-title":"First-trimester markers for the prediction of pre-eclampsia in women with a-priori high risk","volume":"35","author":"Khalil","year":"2010","journal-title":"Ultrasound Obstet. Gynecol."},{"issue":"5","key":"10.1016\/j.preghy.2018.06.005_b0840","doi-asserted-by":"crossref","first-page":"534","DOI":"10.1002\/uog.8848","article-title":"Uterine artery Doppler screening for pre-eclampsia: comparison of the lower, mean and higher first-trimester pulsatility indices","volume":"37","author":"Napolitano","year":"2011","journal-title":"Ultrasound Obstet. Gynecol."},{"issue":"8","key":"10.1016\/j.preghy.2018.06.005_b0845","doi-asserted-by":"crossref","first-page":"598","DOI":"10.1016\/j.placenta.2011.05.006","article-title":"First-trimester placental protein 13, PAPP-A, uterine artery Doppler and maternal characteristics in the prediction of pre-eclampsia","volume":"32","author":"Odibo","year":"2011","journal-title":"Placenta"},{"issue":"8","key":"10.1016\/j.preghy.2018.06.005_b0850","doi-asserted-by":"crossref","first-page":"733","DOI":"10.1038\/hr.2014.62","article-title":"The use of pulse wave velocity in predicting pre-eclampsia in high-risk women","volume":"37","author":"Katsipi","year":"2014","journal-title":"Hypertens. Res."},{"issue":"12","key":"10.1016\/j.preghy.2018.06.005_b0855","doi-asserted-by":"crossref","first-page":"1141","DOI":"10.1002\/pd.2848","article-title":"Uterine artery Doppler and biochemical markers (PAPP-A, PIGF, sFlt-1, P-selectin, NGAL) at 11 + 0 to 13 + 6 weeks in the prediction of late (> 34 weeks) pre-eclampsia","volume":"31","author":"Youssef","year":"2011","journal-title":"Prenat. Diagn."},{"issue":"1","key":"10.1016\/j.preghy.2018.06.005_b0860","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1002\/uog.6280","article-title":"First-trimester maternal serum pregnancy-associated plasma protein-A and pre-eclampsia","volume":"33","author":"Poon","year":"2009","journal-title":"Ultrasound Obstet. Gynecol."},{"issue":"8","key":"10.1016\/j.preghy.2018.06.005_b0865","doi-asserted-by":"crossref","first-page":"781","DOI":"10.1002\/pd.2287","article-title":"First trimester maternal serum placental protein 13 for the prediction of pre-eclampsia in women with a priori high risk","volume":"29","author":"Khalil","year":"2009","journal-title":"Prenat. Diagn."},{"issue":"1","key":"10.1016\/j.preghy.2018.06.005_b0870","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1002\/uog.2686","article-title":"A novel approach to first-trimester screening for early pre-eclampsia combining serum PP-13 and Doppler ultrasound","volume":"27","author":"Nicolaides","year":"2006","journal-title":"Ultrasound Obstet. Gynecol."},{"issue":"11","key":"10.1016\/j.preghy.2018.06.005_b0875","doi-asserted-by":"crossref","first-page":"1384","DOI":"10.1111\/j.1471-0528.2010.02690.x","article-title":"First-trimester placental protein 13 and placental growth factor: markers for identification of women destined to develop early-onset pre-eclampsia","volume":"117","author":"Wortelboer","year":"2010","journal-title":"BJOG"},{"issue":"1","key":"10.1016\/j.preghy.2018.06.005_b0880","doi-asserted-by":"crossref","DOI":"10.1016\/j.ajog.2007.02.025","article-title":"First-trimester placental protein 13 screening for preeclampsia and intrauterine growth restriction","volume":"197","author":"Chafetz","year":"2007","journal-title":"Am. J. Obstet. Gynecol."},{"issue":"8","key":"10.1016\/j.preghy.2018.06.005_b0885","doi-asserted-by":"crossref","first-page":"704","DOI":"10.1002\/pd.1997","article-title":"Down syndrome biochemical markers and screening for preeclampsia at first and second trimester: correlation with the week of onset and the severity","volume":"28","author":"Kang","year":"2008","journal-title":"Prenat. Diagn."},{"issue":"6","key":"10.1016\/j.preghy.2018.06.005_b0890","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1002\/pd.1459","article-title":"Screening in early pregnancy for pre-eclampsia using Down syndrome quadruple test markers","volume":"26","author":"Wald","year":"2006","journal-title":"Prenat. Diagn."},{"issue":"1","key":"10.1016\/j.preghy.2018.06.005_b0895","first-page":"117","article-title":"First trimester inhibin-A concentrations and later development of preeclampsia","volume":"83","author":"Roes","year":"2004","journal-title":"Acta Obstet. Gynecol. Scand."},{"issue":"6","key":"10.1016\/j.preghy.2018.06.005_b0900","doi-asserted-by":"crossref","first-page":"680","DOI":"10.1002\/uog.7621","article-title":"Maternal plasma soluble endoglin at 11\u201313 weeks' gestation in pre-eclampsia","volume":"35","author":"Foidart","year":"2010","journal-title":"Ultrasound Obstet. Gynecol."},{"issue":"6","key":"10.1016\/j.preghy.2018.06.005_b0905","doi-asserted-by":"crossref","first-page":"732","DOI":"10.1002\/uog.6244","article-title":"Maternal serum placental growth factor at 11 + 0 to 13 + 6 weeks of gestation in the prediction of pre-eclampsia","volume":"32","author":"Akolekar","year":"2008","journal-title":"Ultrasound Obstet. Gynecol."},{"issue":"9","key":"10.1016\/j.preghy.2018.06.005_b0910","doi-asserted-by":"crossref","first-page":"1469","DOI":"10.1515\/CCLM.2011.232","article-title":"Inflammatory markers in preeclamptic patients","volume":"49","author":"Can","year":"2011","journal-title":"Clin. Chem. Lab. Med."},{"issue":"5","key":"10.1016\/j.preghy.2018.06.005_b0915","doi-asserted-by":"crossref","first-page":"954","DOI":"10.1097\/HJH.0b013e328352573b","article-title":"Early pregnancy soluble E-selectin concentrations and risk of preeclampsia","volume":"30","author":"Carty","year":"2012","journal-title":"J. Hypertens."},{"issue":"6","key":"10.1016\/j.preghy.2018.06.005_b0920","doi-asserted-by":"crossref","first-page":"662","DOI":"10.1002\/uog.7628","article-title":"Hypertensive disorders in pregnancy: screening by biophysical and biochemical markers at 11\u201313 weeks","volume":"35","author":"Poon","year":"2010","journal-title":"Ultrasound Obstet. Gynecol."},{"issue":"3","key":"10.1016\/j.preghy.2018.06.005_b0925","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1002\/pd.2440","article-title":"Hypertensive disorders in pregnancy: combined screening by uterine artery Doppler, blood pressure and serum PAPP-A at 11\u201313 weeks","volume":"30","author":"Poon","year":"2010","journal-title":"Prenat. Diagn."},{"issue":"4","key":"10.1016\/j.preghy.2018.06.005_b0930","doi-asserted-by":"crossref","DOI":"10.1016\/j.ajog.2010.06.014","article-title":"Screening for preeclampsia using first-trimester serum markers and uterine artery Doppler in nulliparous women","volume":"203","author":"Audibert","year":"2010","journal-title":"Am. J. Obstet. Gynecol."},{"issue":"6","key":"10.1016\/j.preghy.2018.06.005_b0935","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1016\/j.placenta.2012.03.003","article-title":"First trimester maternal serum PIGF, free beta-hCG, PAPP-A, PP-13, uterine artery Doppler and maternal history for the prediction of preeclampsia","volume":"33","author":"Di Lorenzo","year":"2012","journal-title":"Placenta"},{"issue":"4","key":"10.1016\/j.preghy.2018.06.005_b0940","doi-asserted-by":"crossref","first-page":"528","DOI":"10.1016\/j.amjcard.2005.08.072","article-title":"Carotid artery stiffness in obese children with the metabolic syndrome","volume":"97","author":"Iannuzzi","year":"2006","journal-title":"Am. J. Cardiol."},{"issue":"5","key":"10.1016\/j.preghy.2018.06.005_b0945","doi-asserted-by":"crossref","first-page":"801","DOI":"10.1161\/01.HYP.36.5.801","article-title":"Systolic and diastolic blood pressure, pulse pressure, and mean arterial pressure as predictors of cardiovascular disease risk in Men","volume":"36","author":"Sesso","year":"2000","journal-title":"Hypertension"},{"issue":"11","key":"10.1016\/j.preghy.2018.06.005_b0950","doi-asserted-by":"crossref","first-page":"1070","DOI":"10.1002\/pd.4198","article-title":"Second-trimester uterine artery Doppler, PlGF, sFlt-1, sEndoglin, and lipid-related markers for predicting preeclampsia in a high-risk population","volume":"33","author":"Diguisto","year":"2013","journal-title":"Prenat. Diagn."},{"issue":"3","key":"10.1016\/j.preghy.2018.06.005_b0955","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.116.004199","article-title":"Relations of metabolically healthy and unhealthy obesity to digital vascular function in three community-based cohorts: a meta-analysis","volume":"6","author":"Brant","year":"2017","journal-title":"J. Am. Heart Assoc."},{"issue":"9","key":"10.1016\/j.preghy.2018.06.005_b0960","doi-asserted-by":"crossref","first-page":"1142","DOI":"10.1093\/eurheartj\/ehq010","article-title":"Assessment of endothelial function by non-invasive peripheral arterial tonometry predicts late cardiovascular adverse events","volume":"31","author":"Rubinshtein","year":"2010","journal-title":"Eur. Heart J."},{"issue":"2","key":"10.1016\/j.preghy.2018.06.005_b0965","doi-asserted-by":"crossref","first-page":"558","DOI":"10.1016\/j.ajog.2004.08.031","article-title":"Reduced flow-mediated vasodilation is not due to a decrease in production of nitric oxide in preeclampsia","volume":"192","author":"Yamamoto","year":"2005","journal-title":"Am. J. Obstet. Gynecol."},{"issue":"12","key":"10.1016\/j.preghy.2018.06.005_b0970","doi-asserted-by":"crossref","first-page":"924","DOI":"10.5551\/jat.18663","article-title":"Insulin resistance and not BMI is the major determinant of early vascular impairment in patients with morbid obesity","volume":"20","author":"Lupattelli","year":"2013","journal-title":"J. Atheroscler. Thromb."},{"issue":"1","key":"10.1016\/j.preghy.2018.06.005_b0975","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1016\/j.amjcard.2013.08.051","article-title":"Usefulness of brachial artery flow-mediated dilation to predict long-term cardiovascular events in subjects without heart disease","volume":"113","author":"Shechter","year":"2014","journal-title":"Am. J. Cardiol."},{"issue":"8","key":"10.1016\/j.preghy.2018.06.005_b0980","doi-asserted-by":"crossref","first-page":"e104365","DOI":"10.1371\/journal.pone.0104365","article-title":"Visceral adiposity index may be a surrogate marker for the assessment of the effects of obesity on arterial stiffness","volume":"9","author":"Yang","year":"2014","journal-title":"PLoS One"},{"issue":"4","key":"10.1016\/j.preghy.2018.06.005_b0985","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1161\/CIRCULATIONAHA.109.886655","article-title":"Arterial stiffness and cardiovascular events: the Framingham Heart Study","volume":"121","author":"Mitchell","year":"2010","journal-title":"Circulation"}],"container-title":["Pregnancy Hypertension"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2210778918300163?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2210778918300163?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,31]],"date-time":"2025-10-31T07:50:40Z","timestamp":1761897040000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2210778918300163"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,7]]},"references-count":197,"alternative-id":["S2210778918300163"],"URL":"https:\/\/doi.org\/10.1016\/j.preghy.2018.06.005","relation":{},"ISSN":["2210-7789"],"issn-type":[{"value":"2210-7789","type":"print"}],"subject":[],"published":{"date-parts":[[2018,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Preeclampsia biomarkers: An assessment of maternal cardiometabolic health","name":"articletitle","label":"Article Title"},{"value":"Pregnancy Hypertension","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.preghy.2018.06.005","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 International Society for the Study of Hypertension in Pregnancy. Published by Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}